Cristina Carreno

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Discovery of LAS194046: A Potent and Selective pan-Janus Kinase (JAK) Inhibitor with a Suitable Profile for Inhaled Administration.

Discovery of LAS194046: A Potent and Selective pan-Janus Kinase (JAK) Inhibitor with a Suitable Profile for Inhaled Administration.

Journal: Journal of medicinal chemistry
Published: January 16, 2026

A multicentre, randomised, parallel-group, double-blind, vehicle-controlled and open-label, active-controlled study (versus amorolfine 5%), to evaluate the efficacy and safety of terbinafine 10% nail lacquer in the treatment of onychomycosis.

A multicentre, randomised, parallel-group, double-blind, vehicle-controlled and open-label, active-controlled study (versus amorolfine 5%), to evaluate the efficacy and safety of terbinafine 10% nail lacquer in the treatment of onychomycosis.

Journal: Mycoses
Published: September 06, 2021

Identification of 2-Imidazopyridine and 2-Aminopyridone Purinones as Potent Pan-Janus Kinase (JAK) Inhibitors for the Inhaled Treatment of Respiratory Diseases.

Identification of 2-Imidazopyridine and 2-Aminopyridone Purinones as Potent Pan-Janus Kinase (JAK) Inhibitors for the Inhaled Treatment of Respiratory Diseases.

Journal: Journal of medicinal chemistry
Published: October 15, 2019

Novel Inhaled Pan-JAK Inhibitor, LAS194046, Reduces Allergen-Induced Airway Inflammation, Late Asthmatic Response, and pSTAT Activation in Brown Norway Rats.

Novel Inhaled Pan-JAK Inhibitor, LAS194046, Reduces Allergen-Induced Airway Inflammation, Late Asthmatic Response, and pSTAT Activation in Brown Norway Rats.

Journal: The Journal of pharmacology and experimental therapeutics
Published: January 03, 2019

Tofacitinib ameliorates inflammation in a rat model of airway neutrophilia induced by inhaled LPS.

Tofacitinib ameliorates inflammation in a rat model of airway neutrophilia induced by inhaled LPS.

Journal: Pulmonary pharmacology & therapeutics
Published: July 25, 2016

A novel inhaled Syk inhibitor blocks mast cell degranulation and early asthmatic response.

A novel inhaled Syk inhibitor blocks mast cell degranulation and early asthmatic response.

Journal: Pharmacological research
Published: March 23, 2015

Effects of aclidinium bromide in a cigarette smoke-exposed Guinea pig model of chronic obstructive pulmonary disease.

Effects of aclidinium bromide in a cigarette smoke-exposed Guinea pig model of chronic obstructive pulmonary disease.

Journal: American journal of respiratory cell and molecular biology
Published: September 17, 2013

Highly potent aminopyridines as Syk kinase inhibitors.

Highly potent aminopyridines as Syk kinase inhibitors.

Journal: Bioorganic & medicinal chemistry letters
Published: May 16, 2012

An inhibitor of neuronal exocytosis (DD04107) displays long-lasting in vivo activity against chronic inflammatory and neuropathic pain.

An inhibitor of neuronal exocytosis (DD04107) displays long-lasting in vivo activity against chronic inflammatory and neuropathic pain.

Journal: The Journal of pharmacology and experimental therapeutics
Published: March 07, 2012

Pyrazine-based Syk kinase inhibitors.

Pyrazine-based Syk kinase inhibitors.

Journal: Bioorganic & medicinal chemistry letters
Published: January 25, 2012

Characterization of a model of tracheal plasma extravasation in passively sensitized rats using anti-allergic and anti-inflammatory drugs by oral and intratracheal route.

Characterization of a model of tracheal plasma extravasation in passively sensitized rats using anti-allergic and anti-inflammatory drugs by oral and intratracheal route.

Journal: Pulmonary pharmacology & therapeutics
Published: July 21, 2011
Showing 1-11 of 11

Last Updated: 09/26/2026